Sunday, October 12, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Goldman Sachs Analyst Raises Price Target for DR Horton Expresses Optimism for Growth

Elaine Mendonca by Elaine Mendonca
January 11, 2024
in Breaking News
0
Finance_ Investing in stocks
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

On January 11, 2024, Susan Maklari, an analyst at Goldman Sachs, expressed her optimistic stance on D.R. Horton (NYSE:DHI) by reiterating a Buy rating while adjusting the price target from $150 to $173. Her decision to raise the price target signifies her belief in the company’s potential for growth and value. This revised outlook reflects Maklari’s confidence in D.R. Horton’s performance, indicating a positive trajectory for the company’s stock.

[bs_slider_forecast ticker=”DHI”]

DHI Stock Analysis: Positive Momentum and Performance Signals for Investors

On January 11, 2024, DHI stock traded near the top of its 52-week range but experienced a slight drop in price. According to data sourced from CNN Money, DHI was trading above its 200-day simple moving average, indicating a positive trend in its price momentum.

The price of DHI shares decreased by $0.44 since the market last closed, representing a 0.28% drop. This decline may have been influenced by various factors such as market conditions, investor sentiment, or company-specific news.

DHI stock opened at $153.77 on January 11, 2024. This opening price was $0.75 lower than its previous close, suggesting a negative market sentiment at the start of the trading day. However, it is important to note that stock prices are subject to fluctuations throughout the trading day, and the opening price does not necessarily determine the stock’s overall performance.

Trading near the top of its 52-week range indicates that DHI has been experiencing relatively strong performance compared to its historical price levels. This can be seen as a positive signal for investors, as it suggests that the stock has been able to maintain or increase its value over the past year.

Being above its 200-day simple moving average further reinforces the positive momentum of DHI stock. The 200-day moving average is a widely used technical indicator that helps smooth out short-term price fluctuations and provides a broader perspective on the stock’s trend. Trading above this moving average indicates that DHI’s price has been consistently higher than its average price over the past 200 days, which is generally considered a bullish signal.

Investors should consider these factors along with other fundamental and technical analysis before making any investment decisions. It is essential to conduct thorough research and consult with a financial advisor to ensure a comprehensive understanding of the stock’s performance and potential risks.

[stock_market_widget type=”chart” template=”basic” color=”#3946CE” assets=”DHI” range=”1mo” interval=”1d” axes=”true” cursor=”true” range_selector=”true” api=”yf”]

DHI Stock Performance Analysis: Revenue Growth, Net Income Decline, and EPS Stability

DHI Stock Performance on January 11, 2024: Analysis and Insights

Total revenue for DHI stood at $35.46 billion over the past year, representing a 5.92% increase compared to the previous year. However, when comparing the revenue for the fourth quarter of the same year, which came in at $10.50 billion, it is evident that there was no growth or decline, as it remained flat.

The net income for DHI during the past year was $4.75 billion, reflecting a significant decline of 18.98% compared to the previous year. However, in the fourth quarter, DHI managed to rebound, with net income of $1.51 billion, showing an increase of 13.08% compared to the previous quarter.

Earnings per share (EPS) is an important metric for investors to evaluate a company’s profitability on a per-share basis. DHI’s EPS for the past year was $13.82, representing a decrease of 16.27% compared to the previous year. However, in the fourth quarter, the EPS remained flat at $4.45.

These financial figures provide insights into DHI’s performance, but it is crucial to analyze the reasons behind these changes in order to better understand the implications for the company’s stock.

The 5.92% increase in total revenue over the past year suggests that DHI experienced growth in its business operations. However, the flat revenue in the fourth quarter indicates that DHI may have reached a saturation point or faced challenges in sustaining its growth momentum.

The decline in net income by 18.98% over the past year is concerning for investors. However, the rebound in net income in the fourth quarter suggests that DHI implemented measures to improve profitability.

The decrease in EPS by 16.27% over the past year indicates that DHI’s profitability on a per-share basis declined. However, the flat EPS in the fourth quarter indicates that DHI was able to stabilize its profitability per share.

Considering these figures, investors should approach DHI’s stock performance with caution. While the company experienced growth in total revenue over the past year, the decline in net income and EPS raises concerns about its profitability. However, the improvement in net income in the last quarter suggests that DHI may have implemented strategies to address these challenges.

It is essential for investors to conduct further research and analysis before making any investment decisions related to DHI stock.

Tags: DHI
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Finance_Credit

Goldman Sachs Analyst Maintains Sell Rating on Cinemark Holdings

Finance_Capitalization

Goldman Sachs Analyst Maintains Sell Rating on First Industrial Realty with Revised Price Target

Banking Trading online

Citigroups Financial Results for Q4 2023 and FullYear Revealed with Reserves and Charges

Recommended

Food Producers Trading online

TreeHouse Foods Faces Financial Challenges in FY24 Due to Broth Facility Restart

2 years ago
SPDR® SSGA US Large Cap Low Volatility Index ETF Stock

All Eyes on the Fed as Low-Volatility ETF Strategy Faces Test

3 weeks ago
BX stock news

Douglas Lane & Associates LLC Increases Holdings in Alcoa Co. by 40% in First Quarter, Signals Growing Optimism for Aluminum Industry’s Future

2 years ago
Entertainment Trading online

Lions Gate Entertainment Corp Announces Merger with Screaming Eagle Acquisition Corp Creating Lionsgate Studios Corp

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin BigBear.ai BioNTech Broadcom Coinbase Eli Lilly Fiserv IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Nike NIO Nvidia Ocugen Opendoor Oracle Oxford Lane Capital Palantir PayPal Plug Power Realty Income Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Adicet Bio Shares Surge on Promising Clinical Trial Results and Capital Infusion

XpresSpa Group Shares Face Mounting Pressure Following Meeting Cancellation

Can Skillsoft Stock Reverse Its Steep Decline?

Liquidmetal Shares: Technical Signals and Strategic Moves Hint at Potential Reversal

SunHydrogen Set for European Debut with Groundbreaking Technology

SuRo Capital’s Strategic Bet on AI and Crypto Fuels Investor Optimism

Trending

Rockwell Medical Stock
Analysis

Rockwell Medical Shares Plunge Amid Intensifying Sell-Off

by Dieter Jaworski
October 12, 2025
0

Rockwell Medical's stock continues its relentless downward trajectory, with Friday's trading session delivering another devastating blow to...

US Global Investors Stock

Gold Fund Manager’s Shares Defy Sector Strength Amid Political Gridlock

October 12, 2025
FibroGen Stock

FibroGen Shares Extend Decline Amid Mixed Analyst Outlook

October 12, 2025
Adicet Bio Stock

Adicet Bio Shares Surge on Promising Clinical Trial Results and Capital Infusion

October 12, 2025
XpresSpa Group Stock

XpresSpa Group Shares Face Mounting Pressure Following Meeting Cancellation

October 12, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Rockwell Medical Shares Plunge Amid Intensifying Sell-Off
  • Gold Fund Manager’s Shares Defy Sector Strength Amid Political Gridlock
  • FibroGen Shares Extend Decline Amid Mixed Analyst Outlook

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com